Investor AB
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Investor AB reported 13 stock positions worth $4.4 billion. Its top holding was Nasdaq (NDAQ) at 99.5% of the portfolio, followed by Mediwound (MDWD, 0.3%) and Millicom Intl Cellular (TIGO, 0.0%). Compared with Q4 2024, it opened 5 new positions, added to 1 and reduced 3. The biggest buy was a new position in Millicom Intl Cellular (TIGO) and the biggest sale Carnival (CCL, shares −30%).
- Most Recent 13F
- Q2 2026
- Location
- STOCKHOLM, V7
- CIK
- 0000889232
- Portfolio Value
- $4.4B (Q1 2025)
- SEC Filing
- 0001641172-25-010915 ↗ filed May 15, 2025
Holdings Value
Holdings 13 stocks · $4.4B
| NDAQ Nasdaq Inc. | 99.52% | 58,182,426 | $4.4B | No change |
| MDWD Mediwound Ltd. | 0.31% | 872,093 | $13.5M | No change |
| TIGO Millicom Intl Cellular S.A. | 0.05% | 67,781 | $2.1M | New |
| CDNS Cadence Design SYS Inc. | 0.02% | 4,000 | $1.0M | New |
| MCHP Microchip Technology Inc. | 0.02% | 20,000 | $968K | Add +150.0% |
| CHKP Check Point Software Tech | 0.02% | 3,500 | $798K | Reduce -41.7% |
| CLBT Cellebrite Di Ltd. | 0.02% | 35,000 | $680K | Reduce -12.5% |
| COHR Coherent Corp. | 0.01% | 7,000 | $455K | No change |
| BLK BlackRock Inc. | 0.01% | 480 | $454K | No change |
| CCL Carnival Corp. | 0.01% | 21,000 | $410K | Reduce -30.0% |
| WHR Whirlpool Corp. | 0.01% | 3,700 | $333K | New |
| ICE Intercontinental Exchange Inc. | 0.01% | 1,700 | $293K | New |
| BMRN Biomarin Pharmaceutical Inc. | 0.01% | 3,700 | $262K | New |
Portfolio Sells Q4 2024 → Q1 2025
Portfolio Buys Q4 2024 → Q1 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 7 | $14.4B | AZN, NDAQ, MDWD, CLBT, MU |
| Q1 2026 | 10 | $15.1B | AZN, NDAQ, MDWD, CLBT, COHR |
| Q4 2025 | 12 | $5.7B | NDAQ, MDWD, COF, COHR, CELLEBRITE DI LTD |
| Q3 2025 | 12 | $5.2B | NDAQ, MDWD, MCHP, TER, CHKP |
| Q2 2025 | 13 | $5.2B | NDAQ, MDWD, MCHP, TIGO, CDNS |
| Q1 2025 | 13 | $4.4B | NDAQ, MDWD, TIGO, CDNS, MCHP |
| Q4 2024 | 8 | $4.5B | NDAQ, MDWD, CHKP, CLBT, CCL |
| Q3 2024 | 7 | $4.3B | NDAQ, MDWD, CHKP, ONTO, COHR |
| Q2 2024 | 6 | $3.5B | NDAQ, ONTO, CHKP, CCL, COHR |
| Q1 2024 | 10 | $3.7B | NDAQ, MU, AMAT, ONTO, CHKP |